REPROCELL’s BioServe and Biopta tissue procurement networks combine to create a new service isolating human primary cells. REPROCELL Human Tissue Networks REPROCELL, the leading human tissue research...
REPROCELL India (formerly BioServe Biotechnologies) is a state-of-the-art biotechnology company with a mission to serve the life sciences research ecosystem. BioServe Biotechnologies (India) has been...
Acquisition of BioServe Biotechnologies India Pvt. Ltd.
REPROCELL announces that it has acquired all the shares of BioServe Biotechnologies India Pvt. Ltd., (Hyderabad, India hereinafter referred to as “BioServe India”) from Cancer Genetics Inc. (USA)....
REPROCELL’s Dr David Bunton on April 2018 Trade Mission to China with Scottish First Minister Nicola Sturgeon
REPROCELL Europe’s CEO, Dr David Bunton, was part of last week's trade mission to China undertaken by the Scottish First Minister, the Rt. Hon. Nicola Sturgeon MSP. The week-long mission (9-13 April...
Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow
REPROCELL Europe Ltd was pleased to receive a visit from Derek Mackay, the Scottish National Party’s Cabinet Secretary for Finance and the Constitution, on 05 April 2017. CEO Dr David Bunton welcomed...
On Tuesday 20th March 2018 REPROCELL Europe Ltd’s CEO Dr David Bunton appeared in front of the Economy, Jobs and Fair Work Committee at the Scottish Parliament to discuss Scotland’s Economic...
The pharmaceutical industry suffers from very high rates of clinical failure, because preclinical predictions of efficacy often fail to realize a clinical benefit. In part, this can be attributed to...
REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018
The SMi Group’s conference on 3D Cell Culture will be held on 21-22 February 2018.The venue is the Copthorne Tara Hotel in Kensington, London, UK. Find out more at www.3d-CellCulture.com REPROCELL...
REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, was in Durham University (UK) News. Developed at the university by Professor Stefan Prsyborski, Alvetex was first...
REPROCELL Launches New Global Website
Regional companies and brands are integrated into one comprehensive English website demonstrating synergies of REPROCELL’s unique portfolio. Location: REPROCELL Inc. (Yokoyama, Japan) Business Unit:...
New Cell Therapies for Central Nervous System Diseases Using IPSC-Derived Products YOKOHAMA, JAPAN & SALT LAKE CITY, UTAH – November 29th, 2017 – REPROCELL, Inc. announced a collaborative research...
REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
PALO ALTO, CA, November 8, 2017 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research services and procurement of human biospecimens, announced today...
Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017
REPROCELL Europe Ltd’s CEO, Dr David Bunton, has co-authored an article titled New Strategy that has been published in the European Pharmaceutical Review, Autumn 2017. The article is in the EPR’s...
Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)
This following video is from Nicola Sturgeon, First Minister of Scotland's YouTube channel: “First Minister Nicola Sturgeon officially opened the new European headquarters of a life sciences company...
Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow
New headquarters strengthen drug discovery services and translational research, and generate new employment opportunities in Scotland. Press release 10th August 2017. Glasgow, UK. 10th August 2017:...
REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India
Joint Venture Provides Quality Source of Clinically Annotated Tissue Specimens from Vast Indian Population Location: REPROCELL USA Inc. (Beltsville, MD) Business Unit: REPROCELL Discovery Date: May...
REPROCELL and Fox Chase Cancer Center Form Strategic Alliance to Accelerate Biomarker and Genetic Discovery
Alliance Provides Wider Access to Oncology Biospecimens to Accelerate Discovery and Translational Studies Location: REPROCELL USA Inc. (Beltsville, MD) Business Unit: REPROCELL Discovery Date: April...
REPROCELL Europe’s CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research
REPROCELL Europe’s CEO, Dr David Bunton presented at the recent NC3Rs meeting on the use of human tissues in cancer research. The conference considered the potential for human tissue models to help...
REPROCELL Inc. (Japan)’s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her...
Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of REPROCELL Inc, Dr Chikafumi Yokoyama, as well as senior...